A powerful combination of federal policy and changes in tax law is fueling a surge in U.S. pharmaceutical manufacturing. A growing list of companies have announced manufacturing plant developments to be built across the country, and Orange County, a hotspot for pharma and the life sciences industry, could reap some benefits.